470 related articles for article (PubMed ID: 27798331)
21. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
22. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
Eo H; Reed CH; Valentine RJ
Biomed Pharmacother; 2020 Aug; 128():110238. PubMed ID: 32450522
[TBL] [Abstract][Full Text] [Related]
23. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
24. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.
Sanchez AM; Csibi A; Raibon A; Cornille K; Gay S; Bernardi H; Candau R
J Cell Biochem; 2012 Feb; 113(2):695-710. PubMed ID: 22006269
[TBL] [Abstract][Full Text] [Related]
25. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
[TBL] [Abstract][Full Text] [Related]
27. Peroxynitrite induces degradation of myosin heavy chain via p38 MAPK and muscle-specific E3 ubiquitin ligases in C2 skeletal myotubes.
Rom O; Kaisari S; Reznick AZ; Aizenbud D
Adv Exp Med Biol; 2015; 832():1-8. PubMed ID: 25315626
[TBL] [Abstract][Full Text] [Related]
28. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats.
Sheriff S; Kadeer N; Joshi R; Friend LA; James JH; Balasubramaniam A
Mol Cell Endocrinol; 2012 Apr; 351(2):286-95. PubMed ID: 22266196
[TBL] [Abstract][Full Text] [Related]
29. Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt.
Gonçalves DA; Silveira WA; Lira EC; Graça FA; Paula-Gomes S; Zanon NM; Kettelhut IC; Navegantes LC
Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E123-33. PubMed ID: 21952035
[TBL] [Abstract][Full Text] [Related]
30. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
Du M; Shen QW; Zhu MJ; Ford SP
J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
[TBL] [Abstract][Full Text] [Related]
31. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
[TBL] [Abstract][Full Text] [Related]
32. Activation of protein synthesis, regeneration, and MAPK signaling pathways following repeated bouts of eccentric cycling.
Valladares-Ide D; Peñailillo L; Collao N; Marambio H; Deldicque L; Zbinden-Foncea H
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1131-E1139. PubMed ID: 31593504
[TBL] [Abstract][Full Text] [Related]
33. Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
Wang Y; Ma J; Qiu W; Zhang J; Feng S; Zhou X; Wang X; Jin L; Long K; Liu L; Xiao W; Tang Q; Zhu L; Jiang Y; Li X; Li M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235878
[TBL] [Abstract][Full Text] [Related]
34. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
Moylan JS; Smith JD; Chambers MA; McLoughlin TJ; Reid MB
Am J Physiol Cell Physiol; 2008 Oct; 295(4):C986-93. PubMed ID: 18701653
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB
Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773
[TBL] [Abstract][Full Text] [Related]
36. Effect of short-term cold exposure on skeletal muscle protein breakdown in rats.
Manfredi LH; Zanon NM; Garófalo MA; Navegantes LC; Kettelhut IC
J Appl Physiol (1985); 2013 Nov; 115(10):1496-505. PubMed ID: 23908317
[TBL] [Abstract][Full Text] [Related]
37. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ
J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026
[TBL] [Abstract][Full Text] [Related]
38. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
[TBL] [Abstract][Full Text] [Related]
39. GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1.
Yamamoto D; Ikeshita N; Matsubara T; Tasaki H; Herningtyas EH; Toda K; Iida K; Takahashi Y; Kaji H; Chihara K; Okimura Y
Life Sci; 2008 Feb; 82(9-10):460-6. PubMed ID: 18191156
[TBL] [Abstract][Full Text] [Related]
40. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
